SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject12/3/2002 9:41:44 AM
From: nigel bates   of 625
 
Competition on the TRAIL-R2 MAB, as HGSI is taking a look at Kirin's version(s) -

Message 18294584

We are also pleased that we will now have the opportunity to study the Kirin antibodies to TRAIL Receptor-2 alongside our own antibody to determine the optimal drug candidate to enter into clinical trials and, hopefully, to develop and commercialize worldwide...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext